| Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the … AJM Ferreri, K Cwynarski, E Pulczynski, M Ponzoni, M Deckert, LS Politi, ... The Lancet Haematology 3 (5), e217-e227, 2016 | 566 | 2016 |
| The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19 C Schultheiß, E Willscher, L Paschold, C Gottschick, B Klee, SS Henkes, ... Cell Reports Medicine 3 (6), 2022 | 352 | 2022 |
| Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation MH Cheng, S Zhang, RA Porritt, M Noval Rivas, L Paschold, E Willscher, ... Proceedings of the National Academy of Sciences 117 (41), 25254-25262, 2020 | 343 | 2020 |
| Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS … AJM Ferreri, K Cwynarski, E Pulczynski, CP Fox, E Schorb, P La Rosée, ... The Lancet Haematology 4 (11), e510-e523, 2017 | 331 | 2017 |
| Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease C Schultheiß, L Paschold, D Simnica, M Mohme, E Willscher, ... Immunity 53 (2), 442-455. e4, 2020 | 325 | 2020 |
| Resistance to anti-CD19/CD3 BiTE in acute lymphoblastic leukemia may be mediated by disrupted CD19 membrane trafficking F Braig, A Brandt, M Goebeler, HP Tony, AK Kurze, P Nollau, T Bumm, ... Blood, The Journal of the American Society of Hematology 129 (1), 100-104, 2017 | 256 | 2017 |
| Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma I Ben-Batalla, A Schultze, M Wroblewski, R Erdmann, M Heuser, ... Blood, The Journal of the American Society of Hematology 122 (14), 2443-2452, 2013 | 230 | 2013 |
| The epitope recognized by rituximab M Binder, F Otto, R Mertelsmann, H Veelken, M Trepel Blood 108 (6), 1975-1978, 2006 | 209 | 2006 |
| HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children RA Porritt, L Paschold, MN Rivas, MH Cheng, LM Yonker, H Chandnani, ... The Journal of clinical investigation 131 (10), 2021 | 184 | 2021 |
| High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) K Fritsch, B Kasenda, E Schorb, P Hau, J Bloehdorn, R Moehle, S Loew, ... Leukemia 31 (4), 846-852, 2017 | 163 | 2017 |
| Clonal expansion and activation of tissue-resident memory-like TH17 cells expressing GM-CSF in the lungs of patients with severe COVID-19 Y Zhao, C Kilian, JE Turner, L Bosurgi, K Roedl, P Bartsch, AC Gnirck, ... Science Immunology 6 (56), eabf6692, 2021 | 161 | 2021 |
| High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial G Illerhaus, B Kasenda, G Ihorst, G Egerer, M Lamprecht, U Keller, ... The Lancet Haematology 3 (8), e388-e397, 2016 | 158 | 2016 |
| European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when J Caers, L Garderet, KM Kortüm, ME O’Dwyer, NWCJ van de Donk, ... haematologica 103 (11), 1772, 2018 | 145 | 2018 |
| Immunophenotyping of newly diagnosed and recurrent glioblastoma defines distinct immune exhaustion profiles in peripheral and tumor-infiltrating lymphocytes M Mohme, S Schliffke, CL Maire, A Rünger, L Glau, KC Mende, ... Clinical Cancer Research 24 (17), 4187-4200, 2018 | 136 | 2018 |
| The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children RA Porritt, A Binek, L Paschold, MN Rivas, A McArdle, LM Yonker, G Alter, ... The Journal of clinical investigation 131 (20), 2021 | 130 | 2021 |
| Monitoring multiple myeloma by next-generation sequencing of V (D) J rearrangements from circulating myeloma cells and cell-free myeloma DNA A Oberle, A Brandt, M Voigtlaender, B Thiele, J Radloff, A Schulenkorf, ... Haematologica 102 (6), 1105, 2017 | 128 | 2017 |
| Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab M Voigt, F Braig, M Göthel, A Schulte, K Lamszus, C Bokemeyer, M Binder Neoplasia 14 (11), 1023-IN3, 2012 | 128 | 2012 |
| Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells M Binder, B Léchenne, R Ummanni, C Scharf, S Balabanov, M Trusch, ... PloS one 5 (12), e15992, 2010 | 113 | 2010 |
| International Extranodal Lymphoma Study Group (IELSG). Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS … AJ Ferreri, K Cwynarski, E Pulczynski, M Ponzoni, M Deckert, LS Politi, ... Lancet Haematol 3 (5), e217-e227, 2016 | 108 | 2016 |
| Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients S Yousef, J Marvin, M Steinbach, A Langemo, T Kovacsovics, M Binder, ... Blood cancer journal 5 (3), e285-e285, 2015 | 95 | 2015 |
